Ritholtz Wealth Management Purchases 20,203 Shares of Haleon PLC Sponsored ADR $HLN

Ritholtz Wealth Management boosted its position in Haleon PLC Sponsored ADR (NYSE:HLN) by 43.9% during the second quarter, HoldingsChannel reports. The fund owned 66,217 shares of the company’s stock after buying an additional 20,203 shares during the quarter. Ritholtz Wealth Management’s holdings in Haleon were worth $687,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Hanson & Doremus Investment Management grew its holdings in Haleon by 234.1% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after buying an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC grew its holdings in Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after buying an additional 1,491 shares in the last quarter. Banque Transatlantique SA purchased a new position in Haleon during the 1st quarter valued at about $27,000. Ransom Advisory Ltd purchased a new position in Haleon during the 1st quarter valued at about $31,000. Finally, Deutsche Bank AG grew its holdings in Haleon by 267.8% during the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after buying an additional 2,276 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on HLN shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. The Goldman Sachs Group raised Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. Barclays lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. Finally, Wall Street Zen lowered Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $12.33.

Haleon Stock Up 3.0%

Shares of NYSE HLN opened at $9.48 on Friday. Haleon PLC Sponsored ADR has a 12 month low of $8.71 and a 12 month high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $42.22 billion, a price-to-earnings ratio of 24.31, a PEG ratio of 2.77 and a beta of 0.20. The business has a 50-day moving average of $9.41 and a 200-day moving average of $9.99.

Haleon Increases Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a $0.0555 dividend. This is an increase from Haleon’s previous semi-annual dividend of $0.05. This represents a yield of 190.0%. The ex-dividend date of this dividend was Friday, August 15th. Haleon’s payout ratio is currently 28.21%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.